Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2003
10/30/2003CA2482919A1 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
10/30/2003CA2482717A1 Polymorph of ascomycin derivative
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2482249A1 Dry powder inhalant composition
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481786A1 Methods of treating necrotizing enterocolitis
10/30/2003CA2481753A1 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
10/30/2003CA2481749A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/29/2003EP1357181A1 Novel atopic dermatitis-associated gene and proteins
10/29/2003EP1357121A1 Azaring-ether deritatives and their use as nicotinic ach receptor modulators
10/29/2003EP1357120A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1356815A1 Analgesic and antiinflammatory drugs
10/29/2003EP1356811A1 Preventives or remedies for arthritis
10/29/2003EP1356288A1 Screening assay for cotranslational translocation interfering compounds
10/29/2003EP1356085A2 Identification of modulators of dham-kinase and inflammatory diseases
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1355945A2 Flint glycoforms
10/29/2003EP1355937A2 Mammalian alpha-helical protein-53
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355910A1 Formulation of boronic acid compounds
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/29/2003EP1355892A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
10/29/2003EP1355885A1 Pyridine derivatives useful as cyclooxygenase inhibitor
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355658A1 Pyk2 phosphorylation by her3 induces tumor invasion
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1355643A2 Epoxyvibsanin b
10/29/2003EP1355642A2 INHIBITION OF NF-(k)B BY TRITERPENE COMPOSITIONS
10/29/2003EP1355636A1 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1355588A2 Delivery of therapeutic capable agents
10/29/2003EP1169316B9 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/29/2003EP1149092B1 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP1017370B1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
10/29/2003EP0941122B1 Compositions for polynucleotide delivery
10/29/2003EP0920322B9 Use of modified autologous blood for the treatment of autoimmune diseases
10/29/2003EP0703985B1 Recombinant stratum corneum chymotryptic enzyme (scce)
10/29/2003CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation
10/29/2003CN1452497A Combinations of SSRI and estrogenic agents
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1452488A Treatment of inflammatory disorders
10/29/2003CN1452486A Pharmaceutical composition and use method
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451432A Medicine for treating neck, shoulder, waist and leg pains
10/29/2003CN1451421A ÔÇ£GukangÔÇØ patch
10/29/2003CN1451416A Process for preparing novel form of coptidis bolus for clearing away heat of upper part of body
10/29/2003CN1451390A Medicine use of cyclodextrin derivs. and medicine composition thereof
10/29/2003CN1451374A Double-layer slow release ibuprofen and pseudoephedrine hydrochloride tablet
10/29/2003CN1125812C Novel modifications to 2-amino-4 (4-fluorobenzylamino)-1-ethoxy. carbonyl-aminobenzene and processes for preparing said compound
10/29/2003CN1125651C Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
10/28/2003US6639111 Bind on EP4 subtype receptor selectively and binds on the other subtype receptors weakly; side-effect reduction; autoimmune diseases; asthma; bone disorders; degenerative nerve diseases; sleeping disorders; anticoagulants
10/28/2003US6638981 Topical compositions and methods for treating pain
10/28/2003US6638964 Sulfonamide-containing indole compounds
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638933 Bicyclic imidazo-3-yl-amine derivatives
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638524 Cosmetics, foods and beverages supplemented with purified strictinin
10/28/2003US6638499 A nitrogen group containing linkage which is attached one end with a polyoxyalkylene glycol polymer and other end is coupled with a drug; useful for drug delivery
10/28/2003CA2342309C New solid dose form of nanoparticulate naproxen
10/28/2003CA2283939C Non-antigenic branched polymer conjugates
10/28/2003CA2254521C New pyrrol derivatives, their method of preparation and pharmaceutical compositions containing these derivatives
10/28/2003CA2253796C Inhibition of matrix metalloproteases by acetylene containing compounds
10/28/2003CA2252701C Halo-substituted protein kinase c inhibitors
10/28/2003CA2249448C Egg anti-inflammatory composition, method of isolation and use
10/23/2003WO2003087815A2 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087333A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087097A1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug
10/23/2003WO2003087090A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003WO2003087089A1 Piperidine derivatives having ccr3 antagonism
10/23/2003WO2003087088A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087085A1 Heterocyclic amide derivatives as cytokine inhibitors
10/23/2003WO2003087074A1 Phenol compound, process for producing the same, and intermediate therefor
10/23/2003WO2003087072A1 Therapeutic agent for endothelial disorder
10/23/2003WO2003087063A1 Imidazolidine compounds as chemokine receptor modulators
1 ... 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 ... 1272